Rosa Daffini

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

Tiziano Barbui, Alessandro M. Vannucchi, Alberto Álvarez‐Larrán et al. · Leukemia · 2021 · 80 citations · Full text

Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID‐19

Chiara Cattaneo, Rosa Daffini, Chiara Pagani et al. · Cancer · 2020 · 79 citations · Full text

Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey

Enrico Maria Trecarichi, Gabriele Giuliano, Chiara Cattaneo et al. · PLoS ONE · 2019 · 46 citations · Full text

E. Coli, Microbial Pathogens, Klebsiella Pneumoniae +22

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Tiziano Barbui, Valerio De Stefano, Alberto Álvarez‐Larrán et al. · Blood Cancer Journal · 2021 · 33 citations · Full text

Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey

Enrico Maria Trecarichi, Gabriele Giuliano, Chiara Cattaneo et al. · International Journal of Antimicrobial Agents · 2023 · 29 citations · Full text

Italian Perspective Survey, Antibiotic Resistance, Bacterial Pathogens +22